Julie A Cox - Pattern Recognition Receptor DPU and Platform Technology & Science, GlaxoSmithKline

基本信息

Career Trajectory

Bio

No content for now

Research Interests

Papers共 6 篇Author StatisticsCo-AuthorSimilar Experts

By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选

Discovery and Lead-Optimization of 4,5-Dihydropyrazoles As Mono-Kinase Selective, Orally Bioavailable and Efficacious Inhibitors of Receptor Interacting Protein 1 (RIP1) Kinase

Philip A. Harris,Nicolas Faucher,Nicolas George,Patrick M. Eidam,Bryan W. King,Gemma V. White,Niall A. Anderson,Deepak Bandyopadhyay,Allison M. Beal,Veronique Beneton,Scott B. Berger,Nino Campobasso,Sebastien Campos,Carol A. Capriotti,Julie A. Cox,Alain Daugan,Frederic Donche,Marie-Helene Fouchet,Joshua N. Finger,Brad Geddes,Peter J. Gough,Pascal Grondin, Bonnie L. Hoffman,Sandra J. Hoffman, Susan E. Hutchinson,Jae U. Jeong,Emilie Jigorel, Pauline Lamoureux,Lara K. Leister,John D. Lich,Mukesh K. Mahajan,Jamel Meslamani,Julie E. Mosley,Rakesh Nagilla,Pamela M. Nassau,Sze-Ling Ng,Michael T. Ouellette, Kishore K. Pasikanti,Florent Potvain,Michael A. Reilly,Elizabeth J. Rivera,Stephane Sautet,Michelle C. Schaeffer,Clark A. Sehon,Helen Sun,James H. Thorpe,Rachel D. Totoritis,Paris Ward,Natalie Wellaway,David D. Wisnoski,James M. Woolven,John Bertin,Robert W. Marquis

Journal of Medicinal Chemistry（2019）

Cited46Views0WOSBibtex

Discovery of A First-In-Class Receptor Interacting Protein 1 (rip1) Kinase Specific Clinical Candidate (gsk2982772) for the Treatment of Inflammatory Diseases

JOURNAL OF MEDICINAL CHEMISTRY（2017）

Cited393Views0WOSBibtex

393

Author Statistics

Co-Author

Co-Institution

D-Core

合作者
学生
导师

No result temporarily, you can search similar Scholar with the same research interest

Data Disclaimer

The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn